🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Direct-to-angio approach from loCal hOspitals based on a PoInt-of-care bLOo...
Status
Not Yet Recruiting
Location
Hospital Menonita Caguas
Start Date
2025-05
Trial ID
NCT06910163
Treatments Being Tested
This study aimed to investigate whether the biomarkers GFAP, NfL, and VEGF-...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-04-21
Trial ID
NCT07535242
The primary objective of this study is to establish if Glial Fibrillary Aci...
Status
Recruiting
Location
Children's Nebraska
Start Date
2025-05-14
Trial ID
NCT06940232
ALS is characterized by significant genetic, clinical, and biological heter...
Status
Completed
Location
Pioneer Life Sciences Cherrywood
Start Date
2023-03-01
Trial ID
NCT07260981
In this study, high-throughput screening and multi-omics (transcriptomics a...
Status
Completed
Location
Tianjin Medical University General Hospital
Start Date
2021-05-01
Trial ID
NCT04928534
The use of serum biomarkers in the setting of the emergency department (ED)...
Status
Unknown
Location
Fondazione Policlinico Universitario "A. Gemelli" IRCCS
Start Date
2022-10-01
Trial ID
NCT06069674
Treatments Being Tested
The overall aim of this present study is to evaluate Growth Differentiation...
Status
Recruiting
Location
University Hospital Basel
Start Date
2023-05-01
Trial ID
NCT05885724
This is a longitudinal study to examine the effects of a short-term trainin...
Status
Unknown
Location
Hospital Clínico Universitario de Valladolid
Start Date
2024-01-01
Trial ID
NCT06478784
Treatments Being Tested
The goal of this multicenter prospective observational cohort study is to b...
Status
Recruiting
Location
Villa Beretta Rehabilitation Center
Start Date
2026-02-01
Trial ID
NCT07457138
Multiple sclerosis (MS) is the most common acquired neurological disease le...
Status
Active Not Recruiting
Location
CHU de Lyon
Start Date
2023-01-19
Trial ID
NCT05622643
Treatments Being Tested